H. G. Rosenblum

Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018

J. Gargano, T. Querec, E. Unger, 2022, Annals of Internal Medicine.

Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine — United States, 2003–2018

J. Gargano, T. Querec, E. Unger, 2021, MMWR. Morbidity and mortality weekly report.

A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students

P. Remington, J. Tate, D. Currie, 2022, BMC Infectious Diseases.

Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Presence of Anti–SARS-CoV-2 Antibodies Among University Student Dormitory Residents, September–November 2020

P. Remington, D. Currie, R. Westergaard, 2021, Open forum infectious diseases.

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022

R. Link-Gelles, B. Bell, M. Daley, 2022, MMWR. Morbidity and mortality weekly report.

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

E. Woo, K. Ess, M. Wharton, 2021, MMWR. Morbidity and mortality weekly report.